newdrugapprovals.org
The USFDA has approved Navidea Biopharmaceuticals’ Supplemental New Drug Application (sNDA) for the expanded use of Lymphoseek (technetium Tc 99m tilmanocept) Injection
Technetium (99mTc) tilmanocept……………….CAS1262984-82-6 [99mTc]-DTPA-mannosyl-dextran Systematic (IUPAC) name Dextran 3-[(2-aminoethyl)thio]propyl 17-carboxy…